Along with Director D. Polyzogopoulos (4th Clinic, Athens General Hospital of Chest Diseases), three-volume book on Clinical Pulmonology (1st Edition 1993, 2,350 pages \/ 2nd edition 2005, 3,070 pages)<\/p>\n
Translation & editing of Eisenberg, R.L., Chest and Cardiac Imaging, 1993<\/p>\n
Translation & editing of Stradling P., Diagnostic Bronchoscopy, 1996<\/p>\n
Translation of West, J.B., Respiratory Physiology: The Essentials, 1987<\/p>\n
Translation of West, J.B., Pulmonary Pathophysiology: The Essentials, 1986<\/p>\n
Atlas of Bronchoscopy, edited by Thalassinos G. and Polychronopoulos V., translated by Stradling P., 1996<\/p>\n
Pathophysiology of Diffuse Lung Diseases, Hellenic Thoracic Society Publications, 1994<\/p>\n
Metastatic Lung Neoplasms, Hellenic Thoracic Society Publications, 1993<\/p>\n
Slowly Resolving Pneumonia, Athens Medical Society Publications, 1990<\/p>\n
Interpretation of Respiratory Function Tests, Hellenic Thoracic Society Publications, 1991<\/p>\n
Lung Ventilation, Hellenic Thoracic Society Publications, 1991<\/p>\n
Diagnostic & Interventional Bronchoscopy, Postgraduate Seminar of the Hellenic Thoracic Society, 1996<\/p>\n
\u201cDiffuse Lung Disease\u201d, Helliniki Iatriki 63, sup. 3, 430-525, 1997<\/p>\n
Organizing Pneumonia, Hellenic Thoracic Society Publications, 2004<\/p>\n
Histological Classification \/ Staging of Lung Cancer, Hellenic Thoracic Society Publications, 2004<\/p>\n
Polychronopoulos V., Kosmas E., \u201cPleural effusion secondary to Gastrointestinal Disease\u201d, Deckers Pleural Disease; Bouros D: 2004 (2nd Edition 2008, 3rd Edition 2010)<\/p>\n
Pulmonary Circulation, Hellenic Thoracic Society Publications, 2006<\/p>\n
Extrinsic Allergic Alveolitis, Hellenic Thoracic Society Publications, 2007<\/p>\n
Acute, Interstitial and Alveolar Diseases, Hellenic Thoracic Society Publications, 2008<\/p>\n
Clinical Evaluation of Lab Findings in Diffuse Lung Disease, Hellenic Thoracic Society Publications, 2009<\/p>\n
Frequent Questions in Pulmonology, Hellenic Thoracic Society Publications, Pulmonary Embolism, 2010<\/p>\n
Diffuse Alveolar Hemorrhage syndromes: chapter 15;E.Stagaki and V.Polychronopoulos;In:S.K.Jindal\u2019s:Textbook of Pulmonary and Critical Care Medicine;JAYPEE Brothers;2010—
\n2nd Edition : JAYPEE Brothers; 2015<\/p>\n
Airway involvement in ILDs:S.Tryphon,V.Polychronopoulos,in:\u00a0Interstitial Lung Disease;O.Sharma;ED.JAYPEE Brothers,2011<\/p>\n
Acute Exacerbation of Sarcoidodis;In:.Acute Exacerbation of Respiratory Disease: S.SAHN;ED. :JAYPEE Brothers,2011<\/p>\n
1. Respiratory and lower limb muscle function in interstitial lung disease. Panagiotou M1, Polychronopoulos V2, Strange C3,Chron Respir Dis. 2016 Jan 14–<\/p>\n
2. The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit.<\/p>\n
3. Saleh A, L\u00f3pez-Campos JL, Hartl S, Pozo-Rodr\u00edguez F,Roberts CM;PolychronopoulosV.et al: European COPD Audit team.-<\/p>\n
4. PLoS One. 2015 Jul 27;10(7):e0134004. doi: 10.1371\/journal.pone.0134004. eCollection 2015<\/p>\n
5. Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases.
\n6. Papanikolaou IC1, Boki KA2, Giamarellos-Bourboulis EJ3, Kotsaki A4, Kagouridis K5, Karagiannidis N6, Polychronopoulos VS7. Immunol.Lett.2014;Dec;2014
\n7. A prospective study on bacterial and atypical etiology of acute exacerbation in chronic obstructive pulmonary disease.
\nNakou A1, Papaparaskevas J, Diamantea F, Skarmoutsou N, Polychronopoulos V, Tsakris A.
\nFuture Microbiology;2014,November ,,1251<\/p>\n
8. Prediction of Hospitalization Stay in COPD Exacerbations: The AECOPD-F Score. F.Diamantea, V.Polychronopoulos, A. Papaioannou et al:Resp.Care 2014, June<\/p>\n
9. Collateral Damage: Depressive Symptoms in the Partners of COPD Patients.Papaioannou AI, Tsikrika S, Bartziokas K, Karakontaki F, Kastanakis E, Diamantea F, Haniotou A, Papiris S, Polychronopoulos V, Loukides S, Kostikas K.Lung. 2014 May 11<\/p>\n
10. Concomitant sarcoidosis and a connective tissue disease: Review of the clinical findings and postulations concerning their association.<\/p>\n
11. Judson MA, Shapiro L, Freitas S, Polychronopoulos VS, Highland KB. Resp. Med. Febr.2013<\/p>\n
12. A case of tracheal hamartoma resected with loop electrocautery. Panagiotou M, Kalkanis A, Karagiannidis N, Polychronopoulos V. Case Rep Pulmonol. 2013;2013:568590. doi: 10.1155\/2013\/568590. Epub 2013 Jan 14.<\/p>\n
13. Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients.Tzouvelekis A, Ntolios P, Karameris A, Koutsopoulos A, Boglou P, Koulelidis A, Archontogeorgis K, Zacharis G, Drakopanagiotakis F, Steiropoulos P, Anevlavis S, Polychronopoulos V, Mikroulis D, Bouros D.BMC Res Notes. 2012 Nov 26;5:654. doi: 10.1186\/1756-0500-5-654.<\/p>\n
14. Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good.Wells AU, Behr J, Costabel U, Cottin V, Poletti V, Richeldi L; European IPF Consensus Group.Thorax. 2012 Nov;67(11):938-40. doi: 10.1136\/thoraxjnl-2012-202580. Epub 2012 Oct 9. No abstract available.<\/p>\n
15. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations.— 15 Citations-(Aug 2014)–Papaioannou AI, Bartziokas K, Tsikrika S, Karakontaki F, Kastanakis E, Banya W, Haniotou A, Papiris S, Loukides S, Polychronopoulos V, Kostikas K.Eur Respir J. 2012 Aug 9. [Epub ahead of print]
\n16. Decreased apoptotic rate of alveolar macrophages of patients with idiopathic pulmonary fibrosis.Drakopanagiotakis F, Xifteri A, Tsiambas E, Karameris A, Tsakanika K, Karagiannidis N, Mermigkis D, Polychronopoulos V, Bouros D.Pulm Med. 2012;2012:981730. doi: 10.1155\/2012\/981730. Epub 2012 Jun 25.<\/p>\n
17. TREM-1 expression on neutrophils and monocytes of septic patients: relation to the underlying infection and the implicated pathogen.Poukoulidou T, Spyridaki A, Mihailidou I, Kopterides P, Pistiki A, Alexiou Z, Chrisofos M, Dimopoulou I, Drimoussis P, Giamarellos-Bourboulis EJ, Koutelidakis I, Marioli A, Mega A, Orfanos SE, Theodorakopoulou M, Tsironis C, Maggina N, Polychronopoulos V, Tsangaris I; Hellenic Sepsis Study Group.BMC Infect Dis. 2011 Nov 4;11:309. doi: 10.1186\/1471-2334-11-309.<\/p>\n
18. Prognostic value of C-reactive protein in parapneumonic effusions.Skouras V, Boultadakis E, Nikoulis D, Polychronopoulos V, Daniil Z, Kalomenidis I, Gourgoulianis KI.Respirology. 2012 Feb;17(2):308-14. doi: 10.1111\/j.1440-1843.2011.02078.
\n19. .Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters.Papakosta D, Pitsiou G, Daniil Z, Dimadi M, Stagaki E, Rapti A, Antoniou K, Tzouvelekis A, Kontakiotis T, Tryfon S, Polychronopoulos V, Bouros D.Lung. 2011 Oct;189(5):391-9. doi: 10.1007\/s00408-011-9304-5. Epub 2011 Jun 11.<\/p>\n
20. Impact of multidrug resistance on experimental empyema by Pseudomonas aeruginosa.Giamarellos-Bourboulis EJ, Tzepi I, Tsovolou I, Spyridaki A, Tsaganos T, Vaki I, Kotsaki A, Polychronopoulos V.Respiration. 2011;82(1):46-53. doi: 10.1159\/000326893. Epub 2011 Apr 28.<\/p>\n
21. Procalcitonin as an early indicator of outcome in sepsis: a prospective observational study.—22 Citations\u2014Aug.2014Giamarellos-Bourboulis EJ, Tsangaris I, Kanni T, Mouktaroudi M, Pantelidou I, Adamis G, Atmatzidis S, Chrisofos M, Evangelopoulou V, Frantzeskaki F, Giannopoulos P, Giannikopoulos G, Gialvalis D, Gourgoulis GM, Kotzampassi K, Katsifa K, Kofinas G, Kontopidou F, Koratzanis G, Koulouras V, Koutsikou A, Koupetori M, Kritselis I, Leonidou L, Mega A, Mylona V, Nikolaou H, Orfanos S, Panagopoulos P, Paramythiotou E, Papadopoulos A, Papanikolaou X, Pavlaki M, Polychronopoulos V, Skoutelis A, Theodotou A, Vassiliaghou M, Douzinas EE, Gogos C, Armaganidis A; Hellenic Sepsis Study Group.J Hosp Infect. 2011 Jan;77(1):58-63. doi: 10.1016\/j.jhin.2010.07.026. Epub 2010 Dec<\/p>\n
22. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis.\u201428 Citations\u2014(Aug.2014)Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, Aswad B, Karagianidis N, Kastanakis E, Braman SS, Polychronopoulos VChest. 2011 Apr;139(4):893-900. doi: 10.1378\/chest.10-0883. Epub 2010 Aug 19.<\/p>\n
23. Acute exacerbations of interstitial lung diseases. Papanikolaou IC, Drakopanagiotakis F, Polychronopoulos VS.Curr Opin Pulm Med. 2010 Sep;16(5):480-6. doi: 10.1097\/MCP.0b013e32833ae49d. Review.<\/p>\n
24. How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? 20 Citations\u2014Aug 2014 Mermigkis C, Stagaki E, Tryfon S, Schiza S, Amfilochiou A, Polychronopoulos V, Panagou P, Galanis N, Kallianos A, Mermigkis D, Kopanakis A, Varouchakis G, Kapsimalis F, Bouros D.Sleep Breath. 2010 Dec;14(4):387-90. doi: 10.1007\/s11325-010-0336-5. Epub 2010 Mar 16.<\/p>\n
25. Airway involvement in sarcoidosis. 31 Citations Aug 2014– Polychronopoulos VS, Prakash UB.Chest. 2009 Nov;136(5):1371-80. doi: 10.1378\/chest.08-2569. Review.<\/p>\n
26. Chapter: Diffuse alveolar hemorrhage. Karakontaki Foteini, Stagaki E, Polychronopoulos V
\nIn:Textbook of Pulmonary and Critical Care Medicine. Jaypee Brothers 2016<\/p>\n
27. Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?Papaioannou AI, Bartziokas K, Loukides S, Tsikrika S, Karakontaki F, Haniotou A, Papiris S, Stolz D, Kostikas K.Eur Respir J. 2015 Apr 16.<\/p>\n
28. Prediction of hospitalization stay in COPD exacerbations: the AECOPD-F score Diamantea F, Kostikas K, Bartziokas K, Karakontaki F, Tsikrika S, Pouriki S, Polychronopoulos V, Karagiannidis N, Haniotou A, Papaioannou AI. Respir Care. 2014 Nov;59(11):1679-86.<\/p>\n
29. Collateral damage: depressive symptoms in the partners of COPD patients. Papaioannou AI, Tsikrika S, Bartziokas K, Karakontaki F, Kastanakis E, Diamantea F, Haniotou A, Papiris S, Polychronopoulos V, Loukides S, Kostikas K. Lung. 2014 Aug;192(4):519-24.<\/p>\n
30. Impact of Hemodialysis on Dyspnea and Lung Function in End Stage Kidney Disease Patients Anastasios F. Palamidas, Sofia-Antiopi Gennimata, Foteini Karakontaki, Georgios Kaltsakas, Ioanis Papantoniou, Antonia Koutsoukou, Joseph Milic-Emili, Demetrios Vlahakos and Nikolaos G. Koulouris BioMed Research International Volume 2014 , Article ID 212751, 10 pages<\/p>\n
31. Driving-related neuropsychological performance in stable COPD patients. Foteini Karakontaki, Sofia-Antiopi Gennimata, Anastasios F Palamidas, Theocharis Anagnostakos, Epaminondas N Kosmas, Anastasios Stalikas, Charalambos Papageorgiou and Nikolaos G Koulouris. Pulmonary Medicine; Vol 2013: Article ID 297371, 10 pages<\/p>\n
32. Prediction of postoperative lung function and chronic dyspnea in lung cancer patients by using quantitative computed tomography CV Papageorgiou, Dimosthenis Antoniou, Georgios Kaltsakas, Foteini Karakontaki, Panagiotis Misthos, Iris Tsangaridou, Loukas Thanos, NG Koulouris. Science Journal of Clinical Medicine July 2013; 2(4): 134-140<\/p>\n
33. The impact of depressive symptoms on recovery and outcome of hospitalized COPD exacerbations. Papaioannou A, Bartziokas K, Tsikrika S, Karakontaki F, Kastanakis E, Banya W, Haniotou A, Papiris S, Loukides S, Polychronopoulos V, Kostikas K. Eur Respir J 2013; 41:815-823<\/p>\n
34. Pathophysiology of evolution of small airway disease to overt COPD Gennimata SA, Palamidas A, Karakontaki F, Kosmas EN, Koutsoukou A, Loukides S, Koulouris NG COPD 2010;7(4):269-75<\/p>\n
35. Pulmonary thromboembolic disease. Review article. Stagaki \u0395, Apostolakis S, Karakontaki F, Tsaramisli \u039c, Polychronopoulos V, Konstaninides S.Hellenic Journal of cardiology 2012; 530:159-173<\/p>\n
36. Therapeutic dilemma in anti-TB treatment. Strouvalis \u0399, Karakontaki F, Tsaramisli M, Diamantea F, Karagiannidis N. Pneumon, December 2009;76-78<\/p>\n
37. Skouras VS, Kalomenidis I. Pleural fluid tests to diagnose tuberculous pleuritis. Curr Opin Pulm Med, 2016;22: [Epub ahead of printing]<\/p>\n
38. Skouras VS, Kalomenidis I. Effusions caused by drugs. In: Textbook of pleural diseases, 3rd edition. Editors: Light RW, Lee YCG. Taylor & Francis Group, Boca Raton, FL, 2016; p.p. 386-396<\/p>\n
39. Skouras VS, Magkouta S, Psallidas I, Tsilioni I, Maragozidis P, Gourgoulianis KI, Kalomenidis I. Interleukin-27 improves the ability of adenosine deaminase to rule-out tuberculous pleural effusion regardless of pleural tuberculosis prevalence. Infect Dis (Lond), 2015;47(7):477-83<\/p>\n
40. Skouras VS, Pastis NJ, Polychronopoulos V, Silvestri GA. Mediastinal staging in lung cancer. The quest for a cost-effective strategy. Pneumon, 2014;27(1):16-31<\/p>\n
41. Skouras VS, Tanner NT, Silvestri GA. Diagnostic approach to the solitary pulmonary nodule. Semin Respir Crit Care Med, 2013;34(6):762-9<\/p>\n
42. Psathakis K, Skouras V, Chatzivassiloglou F, Tsintiris K. Osteophytes may be a rare cause of recurrent pleural effusions. Monaldi Arch Chest Dis, 2013;79(2):87-9<\/p>\n
43. Skouras V, Boultadakis E, Nikoulis D, Polychronopoulos V, Daniil Z, Kalomenidis I, Gourgoulianis KI. Prognostic value of C-reactive protein in parapneumonic effusions. Respirology, 2012;17(2):308-14<\/p>\n
44. \u03a3\u03ba\u03bf\u03cd\u03c1\u03b1\u03c2 \u0392, \u0391\u03bd\u03c4\u03c9\u03bd\u03bf\u03b3\u03b9\u03b1\u03bd\u03bd\u03ac\u03ba\u03b7 \u039c. \u039f \u03b2\u03ae\u03c7\u03b1\u03c2 \u03c3\u03c4\u03b1 \u03b4\u03b9\u03ac\u03bc\u03b5\u03c3\u03b1 \u03bd\u03bf\u03c3\u03ae\u03bc\u03b1\u03c4\u03b1 \u03c4\u03bf\u03c5 \u03c0\u03bd\u03b5\u03cd\u03bc\u03bf\u03bd\u03bf\u03c2. \u03a3\u03c4\u03bf: \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ac \u03c6\u03c1\u03bf\u03bd\u03c4\u03b9\u03c3\u03c4\u03ae\u03c1\u03b9\u03b1 \u2013 \u0394\u03b9\u03b1\u03c6\u03bf\u03c1\u03bf\u03b4\u03b9\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7 \u03c7\u03c1\u03cc\u03bd\u03b9\u03bf\u03c5 \u03b2\u03ae\u03c7\u03b1. \u03a3\u03c5\u03bd\u03c4\u03ac\u03ba\u03c4\u03b5\u03c2: \u039b\u03bf\u03c5\u03ba\u03af\u03b4\u03b7\u03c2 \u03a3. \u0395\u03ba\u03b4\u03cc\u03c3\u03b5\u03b9\u03c2: \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae \u0395\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1 \u0391\u03b8\u03b7\u03bd\u03ce\u03bd, \u0391\u03b8\u03ae\u03bd\u03b1 2012;24(3):32-51<\/p>\n
45. \u03a3\u03ba\u03bf\u03cd\u03c1\u03b1\u03c2 \u0392, \u0391\u03bd\u03c4\u03c9\u03bd\u03bf\u03b3\u03b9\u03b1\u03bd\u03bd\u03ac\u03ba\u03b7 \u039c\u0395, \u03a0\u03b1\u03bd\u03c3\u03b5\u03bb\u03b7\u03bd\u03ac\u03c2 \u0395, \u03a0\u03bf\u03bb\u03c5\u03c7\u03c1\u03bf\u03bd\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2 \u0392. \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ac \u03c3\u03c5\u03bc\u03c0\u03c4\u03ce\u03bc\u03b1\u03c4\u03b1 \u03ba\u03b1\u03b9 \u03b5\u03c5\u03c1\u03ae\u03bc\u03b1\u03c4\u03b1. \u03a3\u03c4\u03bf: \u0386\u03c4\u03bb\u03b1\u03bd\u03c4\u03b1\u03c2 \u039f\u03b3\u03ba\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2 \u0398\u03ce\u03c1\u03b1\u03ba\u03b1. \u03a3\u03c5\u03bd\u03c4\u03ac\u03ba\u03c4\u03b5\u03c2: \u03a3\u03c5\u03c1\u03af\u03b3\u03bf\u03c2 \u039a, \u0393\u03ba\u03b9\u03cc\u03b6\u03bf\u03c2 \u0393, \u03a7\u03b1\u03c1\u03c0\u03af\u03b4\u03bf\u03c5 \u0391. \u0391\u03b8\u03ae\u03bd\u03b1, \u0395\u03ba\u03b4\u03cc\u03c3\u03b5\u03b9\u03c2 \u03a0\u03b1\u03c1\u03b9\u03c3\u03b9\u03ac\u03bd\u03bf\u03c5, 2012: 133-140<\/p>\n
46. Boultadakis V, Skouras V, Makris D, Damianaki A, Nikoulis DJ, Kiropoulos T, Oikonomidi S, Tsilioni I and Gourgoulianis K. Serum amyloid alpha in parapneumonic effusions. Mediators Inflamm, 2011:237638. Epub 2011 Aug 25<\/p>\n
47. Brixey AG, Luo Y, Skouras V, Awdankiewicz A, Light RW. The efficacy of chest radiographs in detecting parapneumonic effusions. Respirology. 2011 Aug;16(6):1000-4<\/p>\n
48. Psathakis K, Skouras V. Blind needle biopsy of the pleura: why not? Eur Respir Rev, 2011;20(120):120-2<\/p>\n
49. Gogos C, Kotsaki A, Pelekanou A, et al. Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care, 2010 May 26;14(3):R96<\/p>\n
50. \u03a3\u03ba\u03bf\u03cd\u03c1\u03b1\u03c2 \u0392. \u0394\u03b9\u03b1\u03b3\u03bd\u03c9\u03c3\u03c4\u03b9\u03ba\u03ae \u03c0\u03c1\u03bf\u03c3\u03ad\u03b3\u03b3\u03b9\u03c3\u03b7 \u03c5\u03c0\u03b5\u03b6\u03c9\u03ba\u03bf\u03c4\u03b9\u03ba\u03ae\u03c2 \u03c3\u03c5\u03bb\u03bb\u03bf\u03b3\u03ae\u03c2. \u03a3\u03c4\u03bf: \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ac \u03c6\u03c1\u03bf\u03bd\u03c4\u03b9\u03c3\u03c4\u03ae\u03c1\u03b9\u03b1 – \u0394\u03b9\u03b1\u03b3\u03bd\u03c9\u03c3\u03c4\u03b9\u03ba\u03ae \u03c0\u03c1\u03bf\u03c3\u03ad\u03b3\u03b3\u03b9\u03c3\u03b7 \u03b1\u03bd\u03b1\u03c0\u03bd\u03b5\u03c5\u03c3\u03c4\u03b9\u03ba\u03ce\u03bd \u03c0\u03c1\u03bf\u03b2\u03bb\u03b7\u03bc\u03ac\u03c4\u03c9\u03bd \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd \u03bc\u03b7 \u03b5\u03b9\u03b4\u03b9\u03ba\u03cc. \u03a3\u03c5\u03bd\u03c4\u03ac\u03ba\u03c4\u03b5\u03c2: \u039c\u03b9\u03c7\u03b1\u03b7\u03bb\u03af\u03b4\u03b7\u03c2 \u03a3, \u03a0\u03bf\u03bb\u03c5\u03c7\u03c1\u03bf\u03bd\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2 \u0392. \u0395\u03ba\u03b4\u03cc\u03c3\u03b5\u03b9\u03c2: \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae \u0395\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1 \u0391\u03b8\u03b7\u03bd\u03ce\u03bd, \u0391\u03b8\u03ae\u03bd\u03b1 2010;22(2):94-122<\/p>\n
51. Skouras V, Kalomenidis I. Chylothorax: diagnostic approach. Curr Opin Pulm Med, 2010;16:387-393<\/p>\n
52. Skouras V, Awdankiewicz A, Light RW. What size parapneumonic effusions should be sampled? Thorax, 2010;65(1):91<\/p>\n
55. Ther Adv Respir Dis. 2008 Jun;2(3):141-8.Control of asthma. Zervas E, Oikonomidou E, Kainis E, Kokkala M, Petroheilou K, Gaga M.<\/p>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
Along with Director D. Polyzogopoulos (4th Clinic, Athens General Hospital of Chest Diseases), three-volume book […]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":6127,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_exactmetrics_skip_tracking":false,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-18003","page","type-page","status-publish","hentry"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.hygeia.gr\/en\/wp-json\/wp\/v2\/pages\/18003","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hygeia.gr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.hygeia.gr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.hygeia.gr\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hygeia.gr\/en\/wp-json\/wp\/v2\/comments?post=18003"}],"version-history":[{"count":0,"href":"https:\/\/www.hygeia.gr\/en\/wp-json\/wp\/v2\/pages\/18003\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.hygeia.gr\/en\/wp-json\/wp\/v2\/pages\/6127"}],"wp:attachment":[{"href":"https:\/\/www.hygeia.gr\/en\/wp-json\/wp\/v2\/media?parent=18003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}